Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia, Myeloid, Acute 138Precursor Cell Lymphoblastic Leukemia-Lymphoma 137Leukemia 134Lymphoma 130Lymphoma, Non-Hodgkin 124Multiple Myeloma 117Leukemia, Lymphocytic, Chronic, B-Cell 116Lymphoma, Follicular 115Lymphoma, Large B-Cell, Diffuse 114Hodgkin Disease 107Lymphoma, Mantle-Cell 103Myelodysplastic Syndromes 99Lymphoma, Large-Cell, Immunoblastic 96Burkitt Lymphoma 94Lymphoma, B-Cell, Marginal Zone 81Leukemia, Myeloid, Chronic-Phase 76Congenital Abnormalities 76Leukemia, Myeloid, Accelerated Phase 74Myeloproliferative Disorders 71Neoplasms, Plasma Cell 64Leukemia, Myelomonocytic, Chronic 63Blast Crisis 58Waldenstrom Macroglobulinemia 52Recurrence 47Breast Neoplasms 45Primary Myelofibrosis 44Lymphoma, T-Cell, Cutaneous 43Sezary Syndrome 39Mycosis Fungoides 39Anemia, Refractory, with Excess of Blasts 39

Interventions

Cyclophosphamide 8dinutuximab 7Magnetic Resonance Spectroscopy 7Topotecan 6Doxorubicin 6sargramostim 5Vincristine 5Stem Cell Transplantation 5Radiation 5Platinum 5Melphalan 5Isotretinoin 5Colony-Stimulating Factors 5Cisplatin 5Biopsy 51,2-diaminocyclohexaneplatinum II citrate 5Temozolomide 4Specimen Handling 4Irinotecan 4Etoposide 4Congresses as Topic 4Carboplatin 4Thiotepa 3Busulfan 33-Iodobenzylguanidine 3etoposide phosphate 2Razoxane 2Dexrazoxane 2temsirolimus 1lorlatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ganglioneuroblastoma × Peripheral Blood Stem Cell Transplantation × Clear all
NCT01798004 2024-07-15

Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

Children's Oncology Group

Phase 1 Completed
150 enrolled 9 charts
CNS

Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡